A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung-Reference-Cited by-同舟云学术

A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung

Published:2021-11 Issue: Volume: Page:
ISSN:1569-1993
Container-title:Journal of Cystic Fibrosis
language:en
Short-container-title:Journal of Cystic Fibrosis

Author:

Sosinski Lo M.,H Christian Martin,Neugebauer Kerri A.,Ghuneim Lydia-Ann J.,Guzior Douglas V.,Castillo-Bahena Alicia,Mielke Jenna,Thomas Ryan,McClelland Marc,Conrad Doug,Quinn Robert A.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference47 articles.

1. Cystic fibrosis;Davies;BMJ,2007

2. Genotype and Phenotype in Cystic Fibrosis;Zielenski;Respiration,2000

3. The phenotypic consequences of CFTR mutations;Rowntree;Ann. Hum. Genet.,2003

4. Lung microbiota across age and disease stage in cystic fibrosis;Coburn;Sci. Rep.,2015

5. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community–implications for therapeutic management;Delhaes;PLoS One,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Premodulator microbiome alterations associated with postmodulator growth outcomes in pediatric cystic fibrosis: Can we predict outcomes?;Journal of Pediatric Gastroenterology and Nutrition;2024-08-09

2. Pseudomonas aeruginosa in chronic lung disease: untangling the dysregulated host immune response;Frontiers in Immunology;2024-06-28

3. Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes;Journal of Visualized Experiments;2024-04-19

4. Clinical Epidemiology and Impact of Haemophilus influenzae Airways Infections in Adults with Cystic Fibrosis;2024-04-05

5. Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis;The Journal of Infectious Diseases;2024-03-05